For Hospitals, No Benefit for Early Adoption of Financial Incentives
Hospitals with early adoption do not have better process scores, lower mortality than late adopters
Authors: Harig A, Rybarczyk A, Benedetti A, Zimmerman J Abstract Background: Vague, incomplete, or inaccurate drug-allergy histories can be detrimental to patient safety and affect patient care. There is an increased chance of medication errors if details of a drug allergy are not documented. Incomplete or inaccurate allergy histories may also result in increased time spent by health care providers to clarify an order in question. Published literature from the early 1990s showed that a patient interview can facilitate collection of more complete allergy information and could lead to the removal of a documented drug...
Presence of discrimination, the silent witness, effectiveness of leadership can help assess inclusion
Figures for NHS hospitals in England show 5,357 admissions took place, last year - almost 15 every day - where the patient was made critically ill because of a reaction to their food.
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff
Nine-month-old Riley Kinsey, from Kirkby-in-Ashfield, Nottinghamshire, can only eat turkey, carrots, plums and sweet potatoes or his body becomes covered in hives that can cause infections.
(NIH/National Institute of Allergy and Infectious Diseases) New research published in Cell Reports from scientists at the National Institute of Allergy and Infectious Diseases (NIAID) shows how MERS-CoV can adapt to infect cells of a new species, which suggests that other coronaviruses might be able to do the same.
ConclusionNeonates undergoing gastrointestinal surgery have a higher incidence of non-IgE mediated gastrointestinal food allergies. We recommend that formula milk should not be administered to newborns who underwent neonatal gastrointestinal surgeries with full-layer invasion of the small intestine.
The competition in the microinvasive glaucoma surgical (MIGS) space is certainly heating up after todayâs news. FDA has given a nod to Ivantisâ Hydrus Microstent, which will undoubtedly compete against Glaukosâ iStent. Irvine,CA-based Ivantisâ approval comes on the heels of Glaukos winning a nod from FDA for the iStent inject Trabecular Micro-Bypass System. The Hydrus Microstent is used to treat patients with mild to moderate primary open-angle glaucoma in conjunction with cataract surgery. The deviceâs approval is based on the HORIZO...
Let’s begin with a quiz question: Patients may be allergic to: A. oxygen B. carbon C. iodine D. none of the above If you answered anything but “D,” better keep reading. Consider this scenario: If a patient is allergic to penicillin, you would document “penicillin” in the medical records. It would never occur to you to list “antibiotics” as an allergy, and you certainly would not call it a “carbon” allergy for slang, just because penicillin contains carbon. This not an exercise in semantics, but a patient care issue. Iodine is a mineral we all need, intentionally added t...
More News: Allergy | Allergy & Immunology | Brain | Cancer & Oncology | Cardiology | Dermatology | Emergency Medicine | Endocrinology | Gastroenterology | Geriatrics | Heart | Hospitals | Internal Medicine | Neurology | Nurses | Nursing | Opthalmology | Orthopaedics | Respiratory Medicine | Skin | Urology & Nephrology